Literature DB >> 2210857

Parenteral fluoroquinolones in children with life-threatening infections.

R Dagan1, F Schlaeffer, M Einhorn.   

Abstract

The new fluoroquinolones have not been tested in children despite their wide spectrum of in vitro activity and efficacy, because of an observed damage to cartilage in young animals. However, in some cases they may be life-saving. We present three pediatric patients with life threatening infections in whom the fluoroquinolones were used when other antibiotics failed: A seven-year-old boy with meningitis due to multiresistant Acinetobacter calcoaceticus, a three-year-old boy with Job's syndrome with line sepsis due to Staphylococcus epidermidis and a four month-old boy with agammaglobulinemia with mixed infection due to Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter spp. All three children were cured of their infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210857     DOI: 10.1007/bf01643396

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  Chloramphenicol-resistant Salmonella tennessee osteomyelitis.

Authors:  W Kiess; R Haas; W Marget
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

2.  Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

Authors:  L L Shen; A G Pernet
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

Review 3.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

4.  Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals.

Authors:  H Tatsumi; H Senda; S Yatera; Y Takemoto; M Yamayoshi; K Ohnishi
Journal:  J Toxicol Sci       Date:  1978-11       Impact factor: 2.196

5.  Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

Review 6.  Ciprofloxacin: an overview of adverse experiences.

Authors:  P Ball
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

7.  The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

Authors:  A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

  7 in total
  5 in total

Review 1.  Therapeutic strategies for thrombosis: new targets and approaches.

Authors:  Nigel Mackman; Wolfgang Bergmeier; George A Stouffer; Jeffrey I Weitz
Journal:  Nat Rev Drug Discov       Date:  2020-03-04       Impact factor: 84.694

2.  The effects of ciprofloxacin on human chondrocytes in cell culture.

Authors:  M A Mont; S K Mathur; C G Frondoza; D S Hungerford
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 3.  Ventriculitis caused by Klebsiella pneumoniae successfully treated with pefloxacin in a neonate.

Authors:  N Linder; R Dagan; J Kuint; N Keler; G Keren; B Reichman
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

Review 4.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

Review 5.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.